Look for this group of stocks to surge when risk aversion fades, says fund manager, who offers five stock ideas – MarketWatch

China has been talking up its markets, and that’s lifting all boats this morning, with Wall Street poised for a strong start ahead of what’s expected to be the first Fed rate hike in more than three years.

Also helping are some positive rumblings around Ukraine-Russia negotiations as a brutal war continues. Apart from the devastating humanitarian disaster, the crisis has sparked surging commodity prices and inflationary worries.

Those worries have fed to losses in particular for the tech heavy Nasdaq Composite
COMP
and smaller companies
RUT.
This chart from fund house Artemis shows how valuation multiples of small companies have seen harder hits than large-caps over the last six months.


Artemis/Refinitiv

Our call of the day from Artemis’ head of U.S. equity strategies, Cormac Weldon, is optimistic on this asset class. “Once risk aversion abates, we would expect small-caps to outperform: fundamentals and growth will eventually prevail over sentiment,” he said in a note to clients.

For starters, investors in the U.S. have a huge selection of innovative companies to choose from, with active managers often better placed to generate alpha as many of those stocks go overlooked by Wall Street.

He expects “inflationary panic will start to ease,” at some point, noting that used-car prices are starting to tame and investors should expect a disinflationary effect kicking in from the massive technology investment by U.S. companies.

Weldon explains that the market is “extremely polarized” right now, with investors rotating between extremes of value and growth amid a fast-moving inflation and interest-rate debate. He expects stock specifics will become important again, and his cyclical-growth mixed portfolio should do well.

But Artemis is wary of fast-growing companies with big promises, instead focusing on growth and quality. Bio-Techne
TECH
and Syneos Health
SYNH,
and cyclical/financial names like Signature Bank
SBNY
fit that bill, he said.

Maravai Lifesciences
MRVI
is also on his list, as the biopharma group recently spurned a German bid. “t is well-positioned to take advantage of the massive influx of interest and investment flowing into the mRNA area as well as growth in the cell and gene therapy space more broadly,” he said.

And he’s been adding to his Planet Fitness
PLNT
position as COVID disruptions fade and the gym chain has been lagging other reopening stocks. Another plus is that the company is leaner and fitter after it removed excess capacity during the pandemic.

Finally, he likes Pool Corporation
POOL,
which is a niche provider of pool supplies, giving it an enviable degree of pricing power. “Moreover, during the crisis people used their savings – and filled their time – by installing swimming pools,” said Weldon.

The buzz

After some bruising sessions, the Hang Seng
HK:HSI
rebounded 9% as China vowed to keep its stock markets stable and boost economic growth. Beijing has also promised to work with U.S. regulators over delisting concerns, feeding into hefty gains for Alibaba
BABA,
JD.com
JD
and other U.S. -listed Chinese stocks.

Ahead of the Fed outcome and news conference with Chair Jerome Powell, data showed retail sales rising 0.3%, falling short of expectations for a 0.4% gain in February. Import prices cooled slightly, gaining 1.4% in that month from 1.9% previously. Still to come are a home builders’ index and revised business inventories.

Read: Four things to watch at conclusion of Fed meeting on Wednesday

As the bombardment of Kyiv and other cities continues, there are fresh hopes that negotiations may be getting somewhere, after the Kremlin proposed a “Swedish-style” neutral Ukraine. Ukraine’s president Volodymyr Zelenskyy will address U.S. Congress later, after meeting with Polish, Czech Republic and Slovenian heads on Tuesday.

Disney
DIS
employees are calling for walkouts over the next week to protest the company’s response to a Florida’s ‘Don’t Say Gay’ bill.

Biogen stock
BIIB
is getting a lift after sharing more positive long-term data on its Alzheimer’s drug.

Starbucks
SBUX
is climbing after the coffee maker said CEO Kevin Johnson will step down, with ex-head Howard Schulz stepping in for now.

The markets

Stock futures
ES00

YM00
are higher, led by tech
NQ00,
with oil prices
CL00

BRN00
clawing back some ground, a day after entering a bear market. Asia stocks bounced, and European equities
XX:SXXP
are also higher. Gold
GC00
and the dollar
DXY
continue to pull back.

The chart

“As we start the hiking cycle, it’s worth highlighting that hiking cycles in the fiat money era (1971-), when debt has been constantly increasing, have generally eventually led to a financial crisis somewhere around the world,” notes Deutsche Bank strategist Jim Reid in our chart of the day.


Uncredited

“With U.S. equities still at some of their highest valuations in history, with global housing having boomed during the pandemic, and with global debt at record highs, the Fed (and other central banks) shaking the tree is sure to bring something we can add to the events shown in the graph,” he said, though noting that monetary policy usually acts with a lag.

The tickers

These were the most-searched tickers on MarketWatch as of 6 a.m. Eastern Time.

Ticker

Security name

Tesla

GME GameStop

AMC AMC Entertainment

NIO NIO

BABA Alibaba

MULN Mullen Automotive

HYMC Hycroft Mining

AAPL Apple

NVDA Nvidia

FB Meta Platforms

Random reads

Why bitcoin miners are flocking to Kentucky’s Appalachian mountains

Got $2 million to spare? A crazy-rare gold coin marking the 44BC slaying of Julius Caesar is up for auction.

Need to Know starts early and is updated until the opening bell, but sign up here to get it delivered once to your email box. The emailed version will be sent out at about 7:30 a.m. Eastern.

Want more for the day ahead? Sign up for The Barron’s Daily, a morning briefing for investors, including exclusive commentary from Barron’s and MarketWatch writers.

Leave a comment

Your email address will not be published. Required fields are marked *